Skip to content

Author

U. Popat

We have 2 of 1,025 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

A culture change initiative to reduce end-of-life systemic anticancer therapy and intensive healthcare utilization.

607 Background: Receipt of systemic anticancer therapy (SACT) near the end of life (EOL) is associated with potentially low-value care, including increased emergency department visits, hospitalizations, and intensive care unit (ICU) utilization and lower hospice utilization. At UT MD Anderson, a large freestand...

R. Ratan, J. Xiang, Lee Cheng et al. · 0 citations
Open access Sep 2026

iMTSS: an integrated framework for biology- and patient-driven prognosis in myelofibrosis undergoing transplantation.

Relapse and non-relapse mortality after transplantation for myelofibrosis are governed by distinct dimensions, and estimating both outcomes independently with genetic and clinical information, in addition to overall survival, establishes an individualized basis for transplant decision-making.

N. Gagelmann, R. Salit, T. Schroeder et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.